The IGFI receptor gene: A molecular target for disrupted transcription factors

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Genes, Chromosomes and Cancer

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/gcc.10157PMID 12508239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intraabdominal desmoplastic small round cell tumors

  2005cited by this paper
• Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein

  2002cited by this paper
• Results of a pilot study involving the use of an antisense oligodeoxynucleotide directed against the insulin-like growth factor type I receptor in malignant astrocytomas.

  2001cited by this paper
• Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

  2001cited by this paper
• Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.

  2001cited by this paper
• Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells.

  2001cited by this paper
• Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin).

  2001cited by this paper
• Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein.

  2001cited by this paper
• British Journal of Cancer

  2001cited by this paper
• Intraabdominal Desmoplastic Small Round Cell Tumor

  2001cited by this paper
• New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia

  2000cited by this paper
• BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.

  2000cited by this paper
• Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.

  2000cited by this paper
• The age of cancer

  2000cited by this paper
• The IGF System: Molecular Biology, Physiology, and Clinical Applications

  2000cited by this paper
• Insulin-like growth factor I receptor antagonism augments response to chemoradiation therapy in colon cancer cells.

  2000cited by this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cited by this paper
• Down‐regulation of insulin‐like growth factor‐I receptor and insulin receptor substrate‐1 expression in advanced human breast cancer

  2000cited by this paper
• An alternative, nonapoptotic form of programmed cell death.

  2000cited by this paper
• Molecular Biology of the Type 1 IGF Receptor

  1999cited by this paper
• Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.

  1999cited by this paper
• A genetic analysis of PAX3-FKHR, the oncogene of alveolar rhabdomyosarcoma.

  1999cited by this paper
• The IGF System

  1999cited by this paper
• Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor.

  1999cited by this paper
• The IGF system : molecular biology, physiology, and clinical applications

  1999cited by this paper
• Variant EWS-WT1 Chimeric Product in the Desmoplastic Small Round Cell Tumor

  1999cited by this paper
• Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.

  1998cited by this paper
• p53 regulates insulin-like growth factor-I (IGF-I) receptor expression and IGF-I-induced tyrosine phosphorylation in an osteosarcoma cell line: interaction between p53 and Sp1.

  1998cited by this paper
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998cited by this paper
• Molecular Variants of the EWS‐WT1 Gene Fusion in Desmoplastic Small Round Cell Tumor

  1998cited by this paper
• The localization of the insulin‐like growth factor receptor 1 (IGFR‐1) in benign and malignant breast tissue

  1997cited by this paper
• Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation.

  1997cited by this paper
• The Constitutively Active Mutant Gα13Transforms Mouse Fibroblast Cells Deficient in Insulin-like Growth Factor-I Receptor*

  1997cited by this paper
• The Insulin-like Growth Factor-I Receptor Is Required for EWS/FLI-1 Transformation of Fibroblasts*

  1997cited by this paper
• The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number.

  1997cited by this paper
• The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal

  1997cited by this paper
• Protein and messenger ribonucleic acid (mRNA) for the type 1 insulin-like growth factor (IGF) receptor is decreased and IGF-II mRNA is increased in human prostate carcinoma compared to benign prostate epithelium.

  1996cited by this paper
• The IGF-I Receptor Gene Promoter Is a Molecular Target for the Ewing's Sarcoma-Wilms' Tumor 1 Fusion Protein*

  1996cited by this paper
• The role of the insulin-like growth factor system in human cancer.

  1996influential reference
• Transformation by human papillomavirus 16 E6 and E7: role of the insulin-like growth factor 1 receptor.

  1996cited by this paper
• Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.

  1996cited by this paper
• The insulin-like growth factor I receptor: a key to tumor growth?

  1995cited by this paper
• The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.

  1995cited by this paper
• Regulation of insulin-like growth factor I receptor gene expression by Sp1: physical and functional interactions of Sp1 at GC boxes and at a CT element.

  1995cited by this paper
• Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor.

  1995cited by this paper
• The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3

  1995cited by this paper
• Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression

  1995cited by this paper
• Molecular and cellular aspects of the insulin-like growth factor I receptor.

  1995cited by this paper
• Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.

  1995cited by this paper
• Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors.

  1995cited by this paper
• Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes

  1995cited by this paper
• Altered imprinting in lung cancer

  1994cited by this paper
• Chromosomal translocations in human cancer

  1994cited by this paper
• Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.

  1994cited by this paper
• Cell cycle and growth control

  1994cited by this paper
• Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.

  1994cited by this paper
• Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma.

  1994cited by this paper
• In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2.

  1994cited by this paper
• Novel oncogenic mutations in the WT1 Wilms' tumor suppressor gene: a t(11;22) fuses the Ewing's sarcoma gene, EWS1, to WT1 in desmoplastic small round cell tumor.

  1994cited by this paper
• The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer

  1994cited by this paper
• Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

  1993cited by this paper
• Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.

  1993cited by this paper
• WT-1 is required for early kidney development.

  1993cited by this paper
• Role of insulin-like growth factors in embryonic and postnatal growth.

  1993cited by this paper
• Cell cycle and growth control.

  1993cited by this paper
• Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.

  1993cited by this paper
• Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism

  1993cited by this paper
• The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor

  1993cited by this paper
• Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

  1993cited by this paper
• Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.

  1993cited by this paper
• Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development.

  1993cited by this paper
• Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.

  1992cited by this paper
• Structural and functional analysis of the insulin-like growth factor I receptor gene promoter.

  1992cited by this paper
• A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor.

  1992cited by this paper
• Parental imprinting of the mouse insulin-like growth factor II gene.

  1991cited by this paper
• Intra‐abdominal Desmoplastic Small Round‐Cell Tumor: Report of 19 Cases of a Distinctive Type of High‐Grade Polyphenotypic Malignancy Affecting Young Individuals

  1991cited by this paper
• Developmental expression of Sp1 in the mouse

  1991cited by this paper
• Analysis of the human type I insulin-like growth factor receptor promoter region.

  1991cited by this paper
• Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation

  1990cited by this paper
• Developmental regulation of the rat insulin-like growth factor I receptor gene.

  1989cited by this paper
• Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.

  1989cited by this paper
• Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C.

  1984cited by this paper

• The role of growth factors and pseudocapsule in the pathogenesis of uterine fibroids

  2025cites this paper
• Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance

  2023cites this paper
• Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies

  2017cites this paper
• Cytotoxic trichothecene-type sesquiterpenes from the sponge-derived fungus Stachybotrys chartarum with tyrosine kinase inhibition

  2017cites this paper
• Effects of Type 1 Insulin-Like Growth Factor Receptor Silencing in a Human Adrenocortical Cell Line

  2016cites this paper
• Combination of cytotoxic agents and targeted therapy for the treatment of advanced sarcomas: preclinical background and early clinical development

  2016cites this paper
• Morphology and MMP-9, AR and IGFR-1 responses of the seminal vesicle in TRAMP mice model.

  2016cites this paper
• TMPRSS2-ERG fusion protein regulates insulin-like growth factor-1 receptor (IGF1R) gene expression in prostate cancer: involvement of transcription factor Sp1

  2016cites this paper
• Current ideas on the biology of IGFBP-6: More than an IGF-II inhibitor?

  2016cites this paper
• Chapter 21 – Insulin-Like Growth Factor-1 and Its Binding Proteins∗

  2016cites this paper
• Análise da expressão e do silenciamento do receptor tipo 1 do fator de crescimento semelhante à insulina em tumores adrenocorticais humanos

  2015cites this paper
• The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK+ T-cell lymphoma

  2015cites this paper
• MULTILEVEL DEREGULATION OF SURVIVAL MECHANISMS IN NPM-ALK+ T-CELL LYMPHOMA

  2015cites this paper
• Value of expression of insulin-like growth factor-1 receptor in gastric adenocarcinomas and normal gastric tissues.

  2014cites this paper
• Amplification of the Insulin-Like Growth Factor 1 Receptor Gene Is a Rare Event in Adrenocortical Adenocarcinomas: Searching for Potential Mechanisms of Overexpression

  2014cites this paper
• LMP1 Promotes Expression of Insulin-Like Growth Factor 1 (IGF1) To Selectively Activate IGF1 Receptor and Drive Cell Proliferation

  2014cites this paper
• Receptor Cross-Talk in the Biology & Therapeutics Of Pediatric Rhabdoid Brain Tumors

  2014cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon.

  2014cites this paper
• IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer.

  2013cites this paper
• Clinical significance of proliferation, apoptosis and senescence of nasopharyngeal cells by the simultaneously blocking EGF, IGF-1 receptors and Bcl-xl genes.

  2013cites this paper
• The small GTPase N-Ras regulates extracellular matrix synthesis, proliferation and migration in fibroblasts.

  2013cites this paper
• Insulin-like growth factor-binding protein-6 and cancer.

  2013cites this paper
• Prerequisite Genetic Traits for Metastasis

  2013cites this paper
• ROS constitute a convergence nexus in the development of IGF1 resistance and impaired wound healing in a rat model of type 2 diabetes

  2012cites this paper
• Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.

  2012cites this paper
• Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer

  2012cites this paper
• Cancer Genes, Tumor Suppressors, and Regulation of IGF1-R Gene Expression in Cancer

  2012cites this paper
• Targeting apoptosis in cancer cells : improving TRAIL death receptor signaling

  2011cites this paper
• Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes.

  2011cites this paper
• The effects of type 1 IGF receptor inhibition in a mouse model of diabetic kidney disease.

  2011cites this paper
• Influence of energy balance on the somatotrophic axis and matrix metalloproteinase expression in the endometrium of the postpartum dairy cow

  2011cites this paper
• Insulin-Like Growth Factor-1 and Its Binding Proteins

  2010cites this paper
• RETRACTED: Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells

  2010cites this paper
• Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients.

  2010cites this paper
• Análise do número de cópias dos genes IGFIR, SF1 e FGFR4 em tumores adrenocorticais de crianças e adultos

  2010cites this paper
• Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.

  2010cites this paper
• The insulin‐like growth factor system and sarcomas

  2009cites this paper
• The Pathophysiological Significance of IGF-I Receptor Overexpression: New Insights

  2009cites this paper
• Étude de l'implication du système protéolytique neutre calcium-dépendant dans la migration des cellules musculaires tumorales

  2009cites this paper
• Targeting the IGF1 axis in cancer proliferation

  2009cites this paper
• Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis

  2009cites this paper
• Dual silencing of epidermal growth factor and insulin-like growth factor 1 receptors significantly limits growth of nasopharyngeal carcinoma in nude mice

  2008cites this paper
• Differential Expression of Receptor Tyrosine Kinases (RTKs) and IGF-I Pathway Activation in Human Uterine Leiomyomas

  2008cites this paper
• Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.

  2008cites this paper
• Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells.

  2007cites this paper
• Insulin-like Growth Factor-1 Receptor RNA Expression in Hematopoietic Stem Cell Transplanted Patients Does Not Correlate with Graft-versus-Host Disease

  2007cites this paper
• A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.

  2007cites this paper
• The potentiation of curcumin on insulin-like growth factor-1 action in MCF-7 human breast carcinoma cells.

  2007cites this paper
• Regulation of insulin-like growth factor-1 receptor expression and signaling

  2007influential citation
• Insulin-Like Growth Factor (IGF) family and prostate cancer.

  2006cites this paper
• Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.

  2006cites this paper
• IGF1R signalling and its inhibition.

  2006cites this paper
• Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.

  2006cites this paper
• Alternative tyrosine phosphorylation of signaling kinases according to hormone receptor status in breast cancer overexpressing the insulin‐like growth factor receptor type 1

  2006cites this paper
• Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer

  2006cites this paper
• The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.

  2006cites this paper
• Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells

  2006cites this paper
• The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.

  2005cites this paper
• The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells.

  2005cites this paper
• A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer

  2005cites this paper
• Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53.

  2004cites this paper
• Ataxia-telangiectasia mutated gene controls insulin-like growth factor I receptor gene expression in a deoxyribonucleic acid damage response pathway via mechanisms involving zinc-finger transcription factors Sp1 and WT1.

  2004cites this paper
• An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.

  2004cites this paper
• The expression of insulin-like growth factor-I receptor correlates with Fuhrman grading of renal cell carcinomas.

  2004cites this paper
• Expression of insulin‐like growth factor‐I receptor in primary cutaneous carcinomas

  2004influential citation
• Functional and Physical Interactions between BRCA1 and p53 in Transcriptional Regulation of the IGF-IR Gene

  2003cites this paper
• Development of Molecular Agents for IGF Receptor Targeting

  2003cites this paper
• Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment

  2003cites this paper
• Cancer Drug Discovery and Development

  2002cites this paper